About Optellum

Optellum develops AI software for early lung cancer diagnosis, helping healthcare systems discover lung nodule patients faster and reduce time to treatment. The Virtual Nodule Clinic integrates with hospital systems to automatically prioritise patients based on risk, using the world's only FDA cleared and reimbursable radiomics AI for lung cancer prediction. By empowering clinicians with AI enhanced decision support, Optellum has demonstrated measurable real world impact, achieving 71% more interventional procedures and 50% faster time to diagnosis. The platform analyses over one million patient images annually, powered by deep learning models trained on the world's largest chest CT datasets.